1. Home
  2. SGMO vs MATH Comparison

SGMO vs MATH Comparison

Compare SGMO & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • MATH
  • Stock Information
  • Founded
  • SGMO 1995
  • MATH 2015
  • Country
  • SGMO United States
  • MATH Hong Kong
  • Employees
  • SGMO N/A
  • MATH N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • MATH Finance/Investors Services
  • Sector
  • SGMO Health Care
  • MATH Finance
  • Exchange
  • SGMO Nasdaq
  • MATH Nasdaq
  • Market Cap
  • SGMO 122.8M
  • MATH 145.4M
  • IPO Year
  • SGMO 2000
  • MATH N/A
  • Fundamental
  • Price
  • SGMO $0.64
  • MATH $3.16
  • Analyst Decision
  • SGMO Strong Buy
  • MATH
  • Analyst Count
  • SGMO 7
  • MATH 0
  • Target Price
  • SGMO $5.29
  • MATH N/A
  • AVG Volume (30 Days)
  • SGMO 4.9M
  • MATH 178.3K
  • Earning Date
  • SGMO 11-11-2025
  • MATH 09-05-2025
  • Dividend Yield
  • SGMO N/A
  • MATH N/A
  • EPS Growth
  • SGMO N/A
  • MATH N/A
  • EPS
  • SGMO N/A
  • MATH 0.41
  • Revenue
  • SGMO $81,706,000.00
  • MATH $44,567,257.00
  • Revenue This Year
  • SGMO $28.47
  • MATH N/A
  • Revenue Next Year
  • SGMO N/A
  • MATH N/A
  • P/E Ratio
  • SGMO N/A
  • MATH $7.61
  • Revenue Growth
  • SGMO 565.52
  • MATH 165.86
  • 52 Week Low
  • SGMO $0.41
  • MATH $0.88
  • 52 Week High
  • SGMO $3.18
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 49.82
  • MATH 46.15
  • Support Level
  • SGMO $0.62
  • MATH $2.81
  • Resistance Level
  • SGMO $0.69
  • MATH $3.04
  • Average True Range (ATR)
  • SGMO 0.05
  • MATH 0.24
  • MACD
  • SGMO -0.01
  • MATH -0.05
  • Stochastic Oscillator
  • SGMO 25.77
  • MATH 26.36

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

Share on Social Networks: